Valeant Recalls Subpotent AcneFree 3-in-1 Acne Night Repair Foam
Valeant Pharmaceuticals is recalling AcneFree 3-in-1 Acne Night Repair Foam because the salicylic acid ingredient is subpotent and the label is inaccurate.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences. The issues are subpotency of a single ingredient and labeling errors, which align with the 'Low' severity criteria for minor labeling errors or low-risk issues.
Plain-English summary
Valeant Pharmaceuticals is recalling AcneFree 3-in-1 Acne Night Repair Foam (retinol + salicylic acid 1.5% w/v), 3 oz canisters. The recall involves 81,319 canisters distributed nationwide. The affected products are identified by UPC 7 88521 13548 6 and have expiration dates between 10/10/12 and 10/10/14.
The FDA classified this as a Class III recall because the product was found to be subpotent for the salicylic acid ingredient. Additionally, the product is mislabeled because the label either omits or erroneously adds inactive ingredients.
Consumers should stop using the product and return it to the place of purchase for a refund. The recall is being conducted by Valeant Pharmaceuticals, with distribution by University Medical Pharmaceuticals Corp.
The recalled product
- Product
- AcneFree 3-in-1 Acne Night Repair Foam (retinol + salicylic acid 1.5% w/v), 3 oz (85 g) canister, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA 92618, UPC 7 88521 13548 6.
- Manufacturer
- Valeant Pharmaceuticals
- Category
- Drug — Topical Acne Treatment
- Affected units
- 81,319
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Valeant Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Valeant Pharmaceuticals
See all →- ModerateValeant Recalls Subpotent AcneFree 24 Hour Severe Acne Clearing System
FDA (Drugs) · 2012-11-14
- ModerateValeant Recalls Subpotent AcneFree Benzoyl Peroxide Tubes Nationwide
FDA (Drugs) · 2012-11-14
- ModerateValeant Recalls Subpotent AcneFree Acne Pore Cleanser
FDA (Drugs) · 2012-11-14
- LowFDA Recalls Subpotent AcneFree Benzoyl Peroxide Cleanser
FDA (Drugs) · 2012-11-14
- ModerateValeant Recalls Subpotent AcneFree Oil-Free Acne Cleanser
FDA (Drugs) · 2012-11-14
Same hazard · subpotent drug
See all →- LowImprimisRx Recalls Subpotent Povidone Iodine and Proparacaine Ophthalmic Solution
FDA (Drugs) · 2026-09-16
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets
FDA (Drugs) · 2026-09-02
Similar recalls
- LowValeant Recalls CLENZIderm M.D. Acne Treatment Kits Due to Discoloration
FDA (Drugs) · 2017-04-26
- LowJohnson & Johnson Recalls Clean & Clear Foaming Wash for High Salicylic Acid
FDA (Drugs) · 2012-12-26
- LowValeant Recalls CLENZIderm M.D. Pore Therapy Salicylic Acid Acne Treatment
FDA (Drugs) · 2017-04-26
- LowGuthy-Renker Recalls Subpotent Rodan & Fields Proactiv Foundation
FDA (Drugs) · 2015-10-07
- ModerateGuthy-Renker Recalls Rodan & Fields Proactiv Foundation for Subpotent Salicylic Acid
FDA (Drugs) · 2015-10-07
- SevereSagent Pharmaceuticals Recalls Methylprednisolone Sodium Succinate Injection Vials
FDA (Drugs) · 2018-03-21